133 related articles for article (PubMed ID: 726170)
1. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte migration inhibition assay in patients with prostate adenocarcinoma.
Wright GL; Schellhammer PF; Faulconer RJ; Reid JW; Brassil DN; Sieg SM
Prostate; 1981; 2(2):121-31. PubMed ID: 6170963
[TBL] [Abstract][Full Text] [Related]
3. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of leukocyte migration by human breast-cancer-associated antigens.
Kadish AS; Marcus DM; Bloom BR
Int J Cancer; 1976 Nov; 18(5):581-6. PubMed ID: 62721
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of tumour-directed, cell-mediated hypersensitivity detected by means of the leucocyte migration technique in patients with renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1976 Nov; 12(11):889-98. PubMed ID: 991899
[No Abstract] [Full Text] [Related]
7. Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas.
McCoy JL; Jerome LJ; Cannon GB; Pomeroy TC; Connor RJ; Oldham RK; Weese JL; Herberman RB
J Natl Cancer Inst; 1977 Oct; 59(4):1119-25. PubMed ID: 903991
[TBL] [Abstract][Full Text] [Related]
8. In vitro demonstration of cellular hypersensitivity to tumour antigens by means of the leucocyte migration technique in patients with renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1974 Aug; 10(8):523-31. PubMed ID: 4463002
[No Abstract] [Full Text] [Related]
9. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
Emmrich F; Ambrosius H
Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
[TBL] [Abstract][Full Text] [Related]
10. The dose-related effect of tumour extract on the in vitro migration of leucocytes from patients with renal carcinoma.
Kjaer M
Eur J Cancer (1965); 1975 Apr; 11(4):281-9. PubMed ID: 1095377
[No Abstract] [Full Text] [Related]
11. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
12. Immunoassessment of patients with gastric cancer. Using leukocyte migration inhibition (LMI) test.
Kojima O; Uehara Y; Majima T; Ikeda E; Nishioka B; Fujita Y; Majima S
Gastroenterol Jpn; 1983 Aug; 18(4):303-9. PubMed ID: 6628918
[TBL] [Abstract][Full Text] [Related]
13. In vitro demonstration of cell-mediated immunity against human renal carcinoma assessed by the leukocyte migration assay.
Pappas A; Schwarze G
Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):142-50. PubMed ID: 4143237
[No Abstract] [Full Text] [Related]
14. Cell-mediated immune reactivity of Sinclair melanoma-bearing swine to 3 M KCl extracts of swine and human melanoma.
Hook RR; Hamby CV; Millikan LE; Berkelhammer J; Stills HF; Oxenhandler RW
Int J Cancer; 1983 May; 31(5):633-7. PubMed ID: 6852980
[TBL] [Abstract][Full Text] [Related]
15. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
[TBL] [Abstract][Full Text] [Related]
16. Discussion paper: tumor-directed cellular hypersensitivity detected by leucocyte migration in patients with renal carcinoma.
Kjaer M; Bendixen G
Ann N Y Acad Sci; 1976; 276():260-71. PubMed ID: 1071963
[TBL] [Abstract][Full Text] [Related]
17. Leukocyte migration inhibition in human pulmonary neoplasia.
Vose BM; Kimber I; Moore M
J Natl Cancer Inst; 1977 Mar; 58(3):483-8. PubMed ID: 839553
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of cellular immunologic responsiveness in the clinical management of patients with prostatic cancer. III. Inhibition of leucocyte migration.
Ablin RJ; Marrow C; Guinan PD; Bruns GR; Sadoughi N; John T; Bush IM
Urol Int; 1976; 31(6):444-58. PubMed ID: 1006873
[TBL] [Abstract][Full Text] [Related]
19. [Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
Novikov DK; Borisenko ID; Shein IA
Vopr Onkol; 1978; 24(12):50-5. PubMed ID: 83731
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the direct capillary tube leucocyte migration technique (LMCT) and the direct agarose leucocyte migration technique (LMAT) as indicators of tumour-directed cell-mediated hypersensitivity (TCMH) in patients with renal carcinoma.
Kjaer M; Sorensen IB
Acta Allergol; 1976 Apr; 31(2):141-58. PubMed ID: 947138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
